Literature DB >> 28202171

Residual renal function: a paradigm shift.

Jerome Lowenstein1, Jared J Grantham2.   

Abstract

Residual renal function (RRF) in patients undergoing dialysis treatments is currently viewed as glomerular filtrate that has escaped tubular reabsorption. RRF has been quantified as a clearance of urea or creatinine, or urea + creatinine. A major paradigm shift has followed the recognition that a substantial number of organic anion retention solutes (possible "uremic toxins") are protein-bound and therefore are not readily filtered. These protein-bound aryl compounds are secreted by renal tubular organic anion transporters (OATs). This has led to the recognition that RRF in dialysis patients probably represents not only unreabsorbed glomerular filtrate but also a contribution of renal tubular transporters that secrete organic anions. Tubular secretion of hippurate, indoxyl sulfate, and p-cresol sulfate, protein-bound organic anions retained in the plasma of end-stage renal disease patients, can be quantified and used to evaluate the integrity of a function dependent on active solute transport. Here we propose a shift away from the exclusive "glomerulocentric" view of RRF as unreabsorbed glomerular filtrate and of the progression of renal disease as progressive glomerular loss. We expand the definition of RRF to include the combined renal and tubule functions remaining after a disease begins to destroy nephrons and proceeds to anuria. We propose renewed application of the first principles of renal physiology, articulated in the last century by Homer Smith, to the understanding and monitoring of RRF and progression of renal injury in patients during the sometimes long course of and at the end stage of chronic renal disease.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ESRD; biomarkers of progression; chronic kidney disease; hippurate clearance; indoxyl sulfate clearance; organic anion excretion; progressive renal disease

Mesh:

Substances:

Year:  2017        PMID: 28202171     DOI: 10.1016/j.kint.2016.09.052

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

Review 1.  The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.

Authors:  Sanjay K Nigam
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-01-06       Impact factor: 13.820

2.  Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.

Authors:  Kevin T Bush; Prabhleen Singh; Sanjay K Nigam
Journal:  JCI Insight       Date:  2020-04-09

Review 3.  Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function.

Authors:  Ke Wang; Bryan Kestenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-28       Impact factor: 8.237

Review 4.  Measurement and Estimation of Residual Kidney Function in Patients on Dialysis.

Authors:  Tariq Shafi; Andrew S Levey
Journal:  Adv Chronic Kidney Dis       Date:  2018-01       Impact factor: 3.620

5.  Contribution of 'clinically negligible' residual kidney function to clearance of uremic solutes.

Authors:  Stephanie M Toth-Manikowski; Tammy L Sirich; Timothy W Meyer; Thomas H Hostetter; Seungyoung Hwang; Natalie S Plummer; Xin Hai; Josef Coresh; Neil R Powe; Tariq Shafi
Journal:  Nephrol Dial Transplant       Date:  2020-05-01       Impact factor: 5.992

Review 6.  Functional Reserve of the Kidney.

Authors:  Armando Armenta; Magdalena Madero; Bernardo Rodriguez-Iturbe
Journal:  Clin J Am Soc Nephrol       Date:  2021-11-10       Impact factor: 8.237

Review 7.  On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease.

Authors:  Cem Tanriover; Duygu Ucku; Carlo Basile; Katherine R Tuttle; Mehmet Kanbay
Journal:  J Nephrol       Date:  2022-07-11       Impact factor: 4.393

8.  Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis.

Authors:  Sheldon C Leong; Justin N Sao; Abigail Taussig; Natalie S Plummer; Timothy W Meyer; Tammy L Sirich
Journal:  J Am Soc Nephrol       Date:  2018-05-04       Impact factor: 10.121

Review 9.  Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling.

Authors:  Sanjay K Nigam; Kevin T Bush
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

10.  The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.

Authors:  Aleksey Etinger; Sumit R Kumar; William Ackley; Leland Soiefer; Jonathan Chun; Prabjhot Singh; Eric Grossman; Albert Matalon; Robert S Holzman; Bjorn Meijers; Jerome Lowenstein
Journal:  PLoS One       Date:  2018-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.